MedAdvisor Past Earnings Performance
Past criteria checks 0/6
MedAdvisor's earnings have been declining at an average annual rate of -5.4%, while the Healthcare Services industry saw earnings growing at 14.3% annually. Revenues have been growing at an average rate of 50.5% per year.
Key information
-5.4%
Earnings growth rate
14.8%
EPS growth rate
Healthcare Services Industry Growth | 42.6% |
Revenue growth rate | 50.5% |
Return on equity | -16.2% |
Net Margin | -8.3% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Why Investors Shouldn't Be Surprised By MedAdvisor Limited's (ASX:MDR) Low P/S
Apr 24Are Investors Undervaluing MedAdvisor Limited (ASX:MDR) By 44%?
Mar 20Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?
Dec 15Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?
Apr 20MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt
Jun 29Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now
Nov 09Is MedAdvisor (ASX:MDR) A Risky Investment?
Oct 11Is MedAdvisor (ASX:MDR) Using Too Much Debt?
Mar 08MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain
Feb 10What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?
Jan 18The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares
Dec 22What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?
Dec 18Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation
Nov 22Revenue & Expenses BreakdownBeta
How MedAdvisor makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 109 | -9 | 5 | 0 |
30 Sep 23 | 104 | -10 | 4 | 0 |
30 Jun 23 | 98 | -11 | 3 | 0 |
31 Mar 23 | 96 | -8 | 7 | 0 |
31 Dec 22 | 93 | -5 | 7 | 0 |
30 Sep 22 | 80 | -11 | 5 | 0 |
30 Jun 22 | 68 | -17 | 3 | 0 |
31 Mar 22 | 66 | -16 | 3 | 0 |
31 Dec 21 | 64 | -14 | 3 | 0 |
30 Sep 21 | 52 | -14 | 3 | 0 |
30 Jun 21 | 39 | -14 | 3 | 0 |
31 Mar 21 | 28 | -13 | 4 | 0 |
31 Dec 20 | 18 | -12 | 6 | 0 |
30 Sep 20 | 14 | -11 | 6 | 0 |
30 Jun 20 | 10 | -10 | 6 | 0 |
31 Mar 20 | 9 | -9 | 5 | 0 |
31 Dec 19 | 9 | -9 | 4 | 0 |
30 Sep 19 | 9 | -8 | 5 | 0 |
30 Jun 19 | 8 | -8 | 5 | 0 |
31 Mar 19 | 8 | -7 | 5 | 0 |
31 Dec 18 | 7 | -7 | 5 | 0 |
30 Sep 18 | 7 | -6 | 5 | 0 |
30 Jun 18 | 7 | -4 | 4 | 0 |
31 Mar 18 | 6 | -4 | 4 | 0 |
31 Dec 17 | 6 | -4 | 4 | 0 |
30 Sep 17 | 5 | -4 | 4 | 0 |
30 Jun 17 | 4 | -3 | 3 | 0 |
31 Mar 17 | 3 | -4 | 2 | 0 |
31 Dec 16 | 2 | -4 | 2 | 0 |
30 Sep 16 | 2 | -4 | 1 | 0 |
30 Jun 16 | 1 | -3 | 1 | 0 |
31 Mar 16 | 1 | -2 | 1 | 0 |
31 Dec 15 | 2 | -1 | 1 | 0 |
30 Sep 15 | 2 | -1 | 1 | 0 |
30 Jun 15 | 2 | -1 | 0 | 0 |
30 Jun 14 | 1 | -1 | 0 | 0 |
30 Jun 13 | 1 | 0 | 0 | 0 |
Quality Earnings: MDR is currently unprofitable.
Growing Profit Margin: MDR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MDR is unprofitable, and losses have increased over the past 5 years at a rate of 5.4% per year.
Accelerating Growth: Unable to compare MDR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (14.3%).
Return on Equity
High ROE: MDR has a negative Return on Equity (-16.19%), as it is currently unprofitable.